Sign in

CIK 0001745999

  • Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
  1. 4 Open-market sale CEO sold 25,000 shares at an average $107.87 ($2,696,826)
  2. 4 Open-market sale CFO sold 30,000 shares at an average $122.00 ($3,660,000)
  3. 4 Other disposition Director disposed of 400,000 shares (other)
  4. 4 Other disposition 10% owner disposed of 400,000 shares (other)
  5. 4 Open-market sale Director sold 12,045 shares at an average $106.34 ($1,280,897)
  6. 4 Open-market sale President & CSO sold 78,580 shares at an average $107.35 ($8,435,365)
  7. 4 Other acquisition Chief Executive Officer acquired 32 shares (other)
  8. 4 Open-market sale CFO sold 45,000 shares at an average $107.69 ($4,846,016)
  9. 4 Other disposition 10% owner disposed of 800,000 shares (other)
  10. 4 Other disposition Director disposed of 800,000 shares (other)
  11. 4 Insider Changes in Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market sale CEO sold 25,000 shares at an average $70.49 ($1,762,216)
  19. 4 Other acquisition Chief Executive Officer acquired 97 shares (code L)
  20. 4 Grant or award CEO acquired 69,375 shares (grant or award)

Page 10 of 12 · 238 filings